CAMP4 Therapeutics

📍 Cambridge, United States🗓 Founded 2016👥 85 employees💰 Last funded Jan 2016
At CAMP4 Therapeutics, we are pioneering a novel approach to programmable therapeutics. We combine a deep understanding of regulatory RNA and gene expression with a complementary and customizable oligonucleotide modality. Our platform’s proprietary insights enable us to harness the power of RNA to upregulate the expression of genes and unlock the potential to create treatments for hundreds of diseases affecting millions of patients. Join us at the forefront.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2016
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in CAMP4 Therapeutics?
CAMP4 Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did CAMP4 Therapeutics last raise funding?
The most recent investment in CAMP4 Therapeutics recorded on gritt.io was in January 2016.
When was CAMP4 Therapeutics founded?
CAMP4 Therapeutics was founded in 2016.
What industry is CAMP4 Therapeutics in?
CAMP4 Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is CAMP4 Therapeutics based?
CAMP4 Therapeutics is headquartered in Cambridge, United States.